New A.I. technology is generating blueprints for microscopic biological mechanisms that can edit your DNA, pointing to a future when scientists can battle illness and diseases with even greater precision and speed than they can today. Described in a research paper published by a startup called Profluent, the technology is based on the same methods that drive ChatGPT. Profluent has not yet put these synthetic gene editors through clinical trials.
New A.I. technology is generating blueprints for microscopic biological mechanisms that can edit your DNA, pointing to a future when scientists can battle illness and diseases with even greater precision and speed than they can today. Described in a research paper published by a startup called Profluent, the technology is based on the same methods that drive ChatGPT. Profluent has not yet put these synthetic gene editors through clinical trials.